Active Ingredient: OXYBUTYNIN CHLORIDE
Proprietary Name: GELNIQUE
Dosage Form; Route of Administration: GEL; TRANSDERMAL
Strength: 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022204
Product Number: 001
Approval Date: Jan 27, 2009
Applicant Holder Full Name: ABBVIE INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
